STOCK TITAN

Pacific Biosciences grants Meyer 54,945 stock units

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Pacific Biosciences of California, Inc. (PACB) reports that Chief Accounting Officer William Meyer received 54,945 restricted stock units and an option covering 72,309 common shares on November 17, 2026. The RSUs vest in equal annual installments on November 3 of 2027, 2028, 2029 and 2030, subject to his continued status as a service provider. The option has a $1.82 exercise price and vests in 48 equal monthly installments beginning December 3, 2026, also subject to continued service-provider status; it expires November 17, 2036.

Insider MEYER WILLIAM
Role See Remarks
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) F2 72,309 $0.00 $0.00
Grant/Award Common Stock F1 54,945 $0.00 $0.00
Holdings After Transaction: Stock Option (right to buy) — 72,309 options (Direct); Common Stock — 98,945 shares (Direct)
Holdings Before and After: Stock Option (right to buy), 0 to 72,309 options (Direct); Common Stock, 44,000 to 98,945 shares (Direct)
Footnotes (2)
  1. F1. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on November 3 of each of 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
  2. F2. The shares subject to the option will vest in 48 equal monthly installments beginning on December 3, 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
Restricted stock units granted 54,945 units Granted November 17, 2026; vesting is subject to continued service-provider status.
Option underlying shares 72,309 common shares Option granted November 17, 2026; vesting is subject to continued service-provider status.
Option exercise price $1.82 per share Option expires November 17, 2036.
Direct common shares held after RSU award 98,945 shares Reported following the November 17, 2026 award.
Restricted Stock Unit financial
"Each share is represented by a Restricted Stock Unit"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PACB shares did William Meyer hold after his RSU award?

William Meyer's reported direct common-stock holdings after the award were 98,945 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MEYER WILLIAM

(Last)(First)(Middle)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
1305 O'BRIEN DRIVE

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. [ PACB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/17/2026A54,945(1)A$098,945D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$1.8211/17/2026A72,309 (2)11/17/2036Common Stock72,309$072,309D
Explanation of Responses:
1. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on November 3 of each of 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
2. The shares subject to the option will vest in 48 equal monthly installments beginning on December 3, 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
Remarks:
Chief Accounting Officer
/s/ Brett Atkins, Attorney-in-fact11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading